Everence Capital Management Inc Moderna, Inc. Transaction History
Everence Capital Management Inc
- $1.54 Billion
- Q4 2024
A detailed history of Everence Capital Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 7,940 shares of MRNA stock, worth $253,444. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,940
Previous 9,330
14.9%
Holding current value
$253,444
Previous $624,000
47.12%
% of portfolio
0.02%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
899Shares Held
239MCall Options Held
12.1MPut Options Held
20.8M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.29 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.24 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$816 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$561 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$233 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...